138 related articles for article (PubMed ID: 37211960)
21. Prognostic value of baseline metabolic tumor volume measured on
Ito K; Schöder H; Teng R; Humm JL; Ni A; Wolchok JD; Weber WA
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):930-939. PubMed ID: 30488098
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
23. Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
Schmitt RJ; Kreidler SM; Glueck DH; Amaria RN; Gonzalez R; Lewis K; Bagrosky BM; Kwak JJ; Koo PJ
Nucl Med Commun; 2016 Feb; 37(2):122-8. PubMed ID: 26440571
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS
J Vasc Interv Radiol; 2012 Jul; 23(7):943-8. PubMed ID: 22609292
[TBL] [Abstract][Full Text] [Related]
25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.
Yan W; Sun C; Ou X; Hu C
Cancer Imaging; 2023 Feb; 23(1):21. PubMed ID: 36829263
[TBL] [Abstract][Full Text] [Related]
27. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
Seban RD; Moya-Plana A; Antonios L; Yeh R; Marabelle A; Deutsch E; Schwartz LH; Gómez RGH; Saenger Y; Robert C; Ammari S; Dercle L
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2301-2312. PubMed ID: 32206839
[TBL] [Abstract][Full Text] [Related]
28. A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.
Calcagni ML; Mattoli MV; Blasi MA; Petrone G; Sammarco MG; Indovina L; Mulè A; Rufini V; Giordano A
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1682-91. PubMed ID: 23824464
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
[TBL] [Abstract][Full Text] [Related]
30. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis.
Patel P; Finger PT
Am J Ophthalmol; 2012 Apr; 153(4):661-8. PubMed ID: 22264690
[TBL] [Abstract][Full Text] [Related]
31. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
Ludwig JM; Haubold J; Bauer S; Richly H; Siveke JT; Wimmer J; Umutlu L; Schaarschmidt BM; Theysohn JM
Radiol Oncol; 2021 May; 55(3):347-353. PubMed ID: 34051707
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.
Matsuo T; Ogino Y; Ichimura K; Tanaka T; Kaji M
Int J Clin Oncol; 2014 Apr; 19(2):230-9. PubMed ID: 23456141
[TBL] [Abstract][Full Text] [Related]
33. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
34. Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.
Mertens J; De Bruyne S; Van Damme N; Smeets P; Ceelen W; Troisi R; Laurent S; Geboes K; Peeters M; Goethals I; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1214-22. PubMed ID: 23636802
[TBL] [Abstract][Full Text] [Related]
35. Regression of uveal melanoma after ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography/computed tomography.
Lee CS; Lee SC; Lee K; Kwon HJ; Yi JH; Cho A
Retina; 2014 Jan; 34(1):182-7. PubMed ID: 23719400
[TBL] [Abstract][Full Text] [Related]
36. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
Yang XY; Xie F; Tao R; Li AJ; Wu MC
Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
[TBL] [Abstract][Full Text] [Related]
37. First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver.
Ponti A; Denys A; Digklia A; Schaefer N; Hocquelet A; Knebel JF; Michielin O; Dromain C; Duran R
J Nucl Med; 2020 Mar; 61(3):350-356. PubMed ID: 31481579
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.
Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N
Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882
[TBL] [Abstract][Full Text] [Related]
39. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
[TBL] [Abstract][Full Text] [Related]
40. Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.
Francis JH; Catalanotti F; Landa J; Barker CA; Shoushtari AN; Abramson DH
Br J Ophthalmol; 2019 Sep; 103(9):1266-1271. PubMed ID: 30381389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
